• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Arthur B. Pardee, Ph.D.


  • Qiao M, Shi Q, Pardee AB.The pursuit of oncotargets through understanding defective cell regulation.Oncotarget. 2010 Nov;1(7):544-51.
  • Martin KJ, Fournier MV, Reddy GP, Pardee AB.A need for basic research on fluid-based early detection biomarkers.Cancer Res. 2010 Jul 1;70(13):5203-6. Review.
  • Qiao M, Wang Y, Xu X, Lu J, Dong Y, Tao W, Stein J, Stein GS, Iglehart JD, Shi Q, Pardee AB.Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis.Mol Cell. 2010 May 28;38(4):512-23.
  • Sheng S,Qiao M,Pardee AB.Metastasis and AKT activation.J Cell Physiol. 2009 Mar;218(3):451-4. Review.
  • Qiao M,Sheng S,Pardee AB.Metastasis and AKT activation.Cell Cycle. 2008 Oct;7(19):2991-6. Review.
  • Pardee AB,Qiao M.A devious cube of cancer.J Cell Physiol. 2008 Jul;216(1):1-2.
  • Qiao M, Pardee AB.Biomarkers, regerons, and pathways to lethal cancer.J Cell Biochem. 2007 Dec 1;102(5):1076-86. Review.
  • Singh S, Shi Q, Bailey ST, Palczewski MJ, Pardee AB, Iglehart JD, Biswas DK.Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.Mol Cancer Ther. 2007 Jul;6(7):1973-82.
  • Qiao M, Iglehart JD, Pardee AB.Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation.Cancer Res. 2007 Jun 1;67(11):5293-9.
  • Liang P, Meade JD, Pardee AB.A protocol for differential display of mRNA expression using either fluorescent or radioactive labeling.Nat Protoc. 2007;2(3):457-70.
  • Pardee AB.Tumor progression--targets for differential therapy.J Cell Physiol. 2006 Dec;209(3):589-91. Review.
  • Pardee AB.Regulatory molecular biology.Cell Cycle. 2006 Apr;5(8):846-52. Review.
  • Monks NR, Pardee AB.Targeting the NF-kappaB pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs.J Cell Biochem. 2006 May 1;98(1):221-33.
  • Wang A, Li CJ, Reddy PV, Pardee AB.Cancer chemotherapy by deoxynucleotide depletion and E2F-1 elevation.Cancer Res. 2005 Sep 1;65(17):7809-14.
  • Geng Y, Yu Q, Whoriskey W, Dick F, Tsai KY, Ford HL, Biswas DK, Pardee AB, Amati B, Jacks T, Richardson A, Dyson N, Sicinski P.Expression of cyclins E1 and E2 during mouse development and in neoplasia.Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13138-43.
  • Biswas DK, Dai SC, Cruz A, Weiser B, Graner E, Pardee AB.The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers.Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10386-91.
  • Biswas DK, Cruz A, Pettit N, Mutter GL, Pardee AB.A therapeutic target for hormone-independent estrogen receptor-positive breast cancers.Mol Med. 2001 Jan;7(1):59-67.
  • Martin KJ, Graner E, Li Y, Price LM, Kritzman BM, Fournier MV, Rhei E, Pardee AB.High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood.Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2646-51.
  • Martin KJ, Kritzman BM, Price LM, Koh B, Kwan CP, Zhang X, Mackay A, O'Hare MJ, Kaelin CM, Mutter GL, Pardee AB, Sager R.Linking gene expression patterns to therapeutic groups in breast cancer.Cancer Res. 2000 Apr 15;60(8):2232-8.
  • Biswas DK, Reddy PV, Pickard M, Makkad B, Pettit N, Pardee AB.Calmodulin is essential for estrogen receptor interaction with its motif and activation of responsive promoter.J Biol Chem. 1998 Dec 11;273(50):33817-24.
  • Molnar GM, Crozat A, Kraeft SK, Dou QP, Chen LB, Pardee AB.Association of the mammalian helicase MAH with the pre-mRNA splicing complex.Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):7831-6.
  • Zhang JL, Sharma PL, Li CJ, Dezube BJ, Pardee AB, Crumpacker CS.Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase I.Antimicrob Agents Chemother. 1997 May;41(5):977-81.
  • Dezube BJ, Ahlers CM, Lawrence JP, Teng EI, Silberman SL, Pardee AB, Finberg RW.Tenidap inhibits replication of the human immunodeficiency virus-1 in cultured cells.J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jan 1;14(1):13-7.